患有先天性心脏病的新生儿的凝血概况:试点研究
Paraskevi Papadogeorgou1, Serena Valsami2, Maria Boutsikou1
1Neonatal Department, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, 115 28 Athens, Greece.
Medicina (Kaunas, Lithuania)
|February 24, 2024
概括
新生儿的先天性心脏病 (CHD) 显示出中度的凝血障碍,与延长的前列血时间和改变的因子水平. 增加的血栓发生性存在于早期,强调需要对这些婴儿进行仔细监测.
科学领域:
- 新生儿医学 新生儿医学
- 血液学 血液学 血液学
- 心脏病学 心脏病学
背景情况:
- 先天性心脏病 (CHD) 经常与凝血异常有关,影响患者的发病率和死亡率.
- 由于人口异质性,以前的研究未能在患有心血管疾病的新生儿中确定一致的静血模式.
研究的目的:
- 为了研究患有心脏病的新生儿的静血概况.
- 评估ADAMTS-13 (一种具有类型-1血栓状腺素动机的分解蛋白和金属蛋白酶) 在患有心脏病的新生儿中的作用.
- 将这些参数与健康,年龄相匹配的对照进行比较.
主要方法:
- 包括20名患有心血管疾病的新生儿和18名健康新生儿的队列.
- 分析了静血概况,包括前列血时间,第七因子 (FVII),第八因子 (FVIII),·维勒布兰德因子 (VWF),瑞斯托辅因子活性 (Rcof) 和ADAMTS-13度.
主要成果:
- 与对照组相比,患有心脏病的新生儿表现出明显延长的前列血时间和降低的FVII水平.
- 在CHD组中观察到FVIII,VWF和Rcof水平升高.
- 在心血管疾病组,ADAMTS-13度较低,但在统计学上并不显著.
结论:
- 患有心血管疾病的新生儿的凝血概况在疾病进程的早期中适度受损.
- 尽管有障碍,但血栓发生率的增加是显而易见的,需要临床关注.
- 在这个患者群体中,凝血的发育方面是明显的,表明平衡但可变的静血机制.
相关概念视频
Fetal Circulation
969
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
969
Disorders of Hemostasis
906
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
906
Coagulation
6.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K


